Why Cerebras Systems Stock Hit a New 52-Week Low: OpenAI Concerns and Share Supply Pressure
Cerebras Systems (NASDAQ: CBRS) shares tumbled on October 12, 2026, hitting a fresh 52-week low as investors reassessed the artificial intelligence chipmaker’s growth prospects, its relationship with OpenAI and the threat of competition from larger technology companies.
The stock fell about 10% during Monday’s session, touching an intraday low near $145.76 before closing at approximately $147.89. That left shares well below their $185 initial public offering price in May and far beneath their recent highs.
The sell-off reflects more than a routine pullback in a volatile technology stock. Cerebras has built its investment story around high-speed AI inference computing and major customer commitments. Reports suggesting that OpenAI is using Nvidia hardware for a newer AI model have raised questions about how much of that opportunity Cerebras can capture.
An approaching lockup expiration is adding another source of uncertainty. Together, these developments have made investors more cautious about a company whose valuation depends heavily on future growth.
Why Is Cerebras Stock Falling?
1. Questions about OpenAI's use of Cerebras chips
The immediate concern stems from an industry report, first circulated in late September, suggesting that OpenAI’s GPT-6.1 Sol “Ultrafast” inference tier was running on Nvidia graphics processing units rather than Cerebras hardware. The report has not established that OpenAI is abandoning Cerebras, but it has challenged expectations about how the two companies will divide future computing workloads.
This matters because OpenAI is central to Cerebras’s growth strategy.
In January 2026, Cerebras announced a multiyear agreement with OpenAI valued at more than $20 billion. Under the arrangement, OpenAI committed to purchasing 750 megawatts of Cerebras AI inference computing capacity over three years, with deployment expected in stages. OpenAI also has an option to purchase additional capacity.
The agreement gives Cerebras a substantial opportunity to expand revenue and establish its technology in production AI services. However, investors need to distinguish a contractual commitment from an assumption that every future OpenAI model or workload will use Cerebras chips.
Large AI developers operate diverse computing systems. They can choose different hardware for different tasks depending on speed, cost, availability, software compatibility and energy efficiency.
If OpenAI directs some workloads to Nvidia or other providers, Cerebras could face uncertainty about future expansion opportunities, even if its existing agreement remains in place.
2. Microsoft is expanding its own AI chip programme
Competition is another pressure point. Microsoft announced its Maia 300 custom AI chip on October 12, saying it planned to deploy the technology extensively across its own AI services beginning in 2027. The company is targeting improvements in computing efficiency and cost as it builds out its infrastructure.
Microsoft’s move does not mean Cerebras has lost a customer or a contract. Rather, it highlights a broader industry trend: major cloud and AI companies increasingly want greater control over their computing costs and hardware supply.
For Cerebras, this creates a difficult competitive environment. Its wafer-scale processor architecture is designed to deliver high-speed AI processing, particularly for inference—the stage when a trained model generates answers or performs tasks.
But performance alone does not guarantee commercial success. Buyers also consider total operating costs, system integration, reliability, software support and the ability to scale deployments.
Nvidia remains a formidable competitor because of its established GPU ecosystem, while hyperscalers such as Microsoft are investing in alternatives designed around their own workloads. Cerebras must demonstrate that its technology offers a compelling advantage for specific applications.
Lockup Expiration Adds Selling Pressure
A second near-term concern is the expected expiration of restrictions on certain existing shareholders.
Investing.com reported that approximately 19.4 million shares could become eligible for sale around October 14, 2026.
A lockup is an agreement that restricts certain shareholders—often company insiders, employees and early investors—from selling their shares for a specified period after an IPO. When restrictions expire, those holders may gain the ability to sell, subject to applicable securities rules and any other restrictions.
The expiration does not mean all eligible shares will immediately be sold. Some shareholders may retain their positions, while others may sell only a portion.
Nevertheless, the prospect of additional shares entering the market can weigh on a stock, especially when sentiment is already weak. Investors may reduce their exposure in anticipation of selling pressure, and potential buyers may wait for the market to absorb any additional supply.
For a recently listed company with a volatile share price, this supply-demand imbalance can amplify short-term movements.
The October 14 date is therefore an important event to monitor, but it should not be treated as a guaranteed catalyst for another decline.
How Far Has CBRS Fallen Since Its IPO?
Cerebras priced its initial public offering at $185 per share in May 2026.
By the October 12 close of about $147.89, the stock had fallen approximately 20% below that offering price. It had also retreated substantially from the 52-week high of $386.34 reported in its market data.
The decline signals a sharp change in investor expectations. Early enthusiasm centred on Cerebras’s specialised chip architecture, demand for faster AI inference and the scale of its OpenAI agreement. More recently, investors have focused on customer concentration, competition, execution risks and the possibility that AI infrastructure spending may not translate into revenue as quickly as expected.
A lower share price does not, by itself, prove that a company is undervalued. Nor does a 52-week low automatically mean that the stock must continue falling. The key question is whether the new price better reflects the company's likely future cash flows and risks.
Investors should also remember that an IPO price is the price at which shares were offered to public investors, not a guarantee of fair value or a permanent support level.
What Cerebras's Business Means for Its Long-Term Outlook
Cerebras is focused on a part of the AI market that could expand as businesses use AI models more frequently. Inference computing supports activities such as generating text, assisting with software development and responding to user requests. Faster inference can improve responsiveness and may enable new applications.
The company's technology aims to address this demand with wafer-scale processors and specialised systems designed for AI workloads. Its partnership with Amazon Web Services also provides a route to broader distribution: Cerebras announced a strategic collaboration with AWS in 2026 to bring its inference computing into AWS data centres and services.
These relationships offer potential growth opportunities, but they do not remove the risks associated with a young public company operating in a fast-changing industry.
Customer concentration is particularly important. Cerebras's SEC filings describe a business whose revenue has historically depended on a limited number of customers, with large agreements expected to shape future performance.
That concentration can produce rapid growth when major customers expand their purchases. It can also create volatility if a customer changes deployment schedules, reduces demand or delays payments.
For shareholders, the long-term case depends on whether Cerebras can convert technical advantages and contractual commitments into recurring, profitable revenue while broadening its customer base.
What Investors Should Watch Next
Several developments could help determine whether the sell-off continues or the stock stabilises.
OpenAI deployment updates: Investors should look for evidence of how the 750-megawatt commitment progresses and whether additional workloads are deployed as expected.
The October 14 lockup expiration: The number of shares eligible for sale is not the same as the number actually sold. Subsequent trading and disclosures may help clarify the impact.
Competition from Nvidia and custom chips: Evidence of real-world performance, cost advantages and customer adoption will matter more than broad claims about chip speed.
Quarterly financial results: Revenue growth, customer concentration, margins, cash requirements and deployment costs will help reveal whether commercial commitments are translating into sustainable performance.
Broader AI spending: If large technology companies become more cautious about infrastructure budgets, specialised chip providers could face greater scrutiny.
The wider technology market also experienced pressure on October 12, with the Nasdaq Composite falling about 0.4%. That backdrop may have contributed to risk aversion, but the scale of Cerebras's decline and the company-specific concerns point to additional pressures beyond the broader market move.
Cerebras Stock Outlook: The Key Takeaway
Cerebras Systems hit a new 52-week low as doubts about future OpenAI workloads, intensifying competition and the approaching shareholder lockup expiration combined to weaken investor confidence. Its OpenAI and AWS relationships still offer meaningful opportunities, but investors need evidence that those opportunities can support durable revenue growth.
The next important signals will be actual customer deployments, the impact of newly eligible shares and the company's financial progress. Until those become clearer, CBRS is likely to remain sensitive to news about AI hardware demand and customer spending.
Follow the blog for more updates and analysis on technology stocks, AI businesses and global financial markets.
This article is for informational and educational purposes only and should not be considered investment advice.